Endovenous laser ablation (EVLA) vs foam sclerotherapy
Recurrence · people with GSV incompetence
It is very uncertain whether endovenous laser ablation (EVLA) changes recurrence (< 5 years) compared with ultrasound‐guided foam sclerotherapy (UGFS) (very low certainty).
1 finding from 1 review
- OR 0.68 [0.2, 2.36]2 studies · 443 participantsVery low